Galapagos NV Selects Pre-Clinical Candidate For Cystic Fibrosis

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MECHELEN, Belgium, Dec. 16, 2013 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext: GLPG) announced today that it nominated a pre-clinical candidate potentiator for clinical development in its cystic fibrosis (CF) program.

Help employers find you! Check out all the jobs and post your resume.

Back to news